Glycogen hyperphosphorylation underlies lafora body formation (Q42815700)

7 November 2017

Glycogen hyperphosphorylation underlies lafora body formation (English)

1 reference

7 November 2017

Julie Turnbull

1

1 reference

7 November 2017

Peixiang Wang

2

1 reference

7 November 2017

Jean-Marie Girard

3

1 reference

7 November 2017

Alessandra Ruggieri

4

1 reference

7 November 2017

Tony J Wang

5

1 reference

7 November 2017

Arman G Draginov

6

1 reference

7 November 2017

Alexander P Kameka

7

1 reference

7 November 2017

Nela Pencea

8

1 reference

7 November 2017

Xiaochu Zhao

9

1 reference

7 November 2017

Cameron A Ackerley

10

1 reference

7 November 2017

Berge A Minassian

11

1 reference

7 November 2017

1 December 2010

1 reference

7 November 2017

1 reference

7 November 2017

68

1 reference

7 November 2017

6

1 reference

7 November 2017

925-933

1 reference

Glycogen and its Metabolism

7 November 2017

1 reference

Beitrag zur Histopathologie der myoklonischen Epilepsie

21 January 2018

1 reference

Lafora's disease: towards a clinical, pathologic, and molecular synthesis

21 January 2018

1 reference

Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene

21 January 2018

1 reference

A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora'

21 January 2018

1 reference

Glycogen branching enzyme in Lafora myoclonus epilepsy.

21 January 2018

1 reference

PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

21 January 2018

1 reference

Characterization of the human P-type 6-phosphofructo-1-kinase gene promoter in neural cell lines

21 January 2018

1 reference

Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy

21 January 2018

1 reference

Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation

21 January 2018

1 reference

Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy

21 January 2018

1 reference

Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway

21 January 2018

1 reference

AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex

21 January 2018

1 reference

Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy.

21 January 2018

1 reference

Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice

21 January 2018

1 reference

Abnormal metabolism of glycogen phosphate as a cause for Lafora disease

21 January 2018

1 reference

Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.

21 January 2018

1 reference

Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates

21 January 2018

1 reference

Mutations in NHLRC1 cause progressive myoclonus epilepsy

21 January 2018

1 reference

Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin

21 January 2018

1 reference

A highly efficient recombineering-based method for generating conditional knockout mutations

21 January 2018

1 reference

Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy

21 January 2018

1 reference

Dual regulation of muscle glycogen synthase during exercise by activation and compartmentalization.

21 January 2018

1 reference

Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin

21 January 2018

1 reference

Atypical ubiquitin chains: new molecular signals. 'Protein Modifications: Beyond the Usual Suspects' review series

21 January 2018

1 reference

Lafora disease due to EPM2B mutations: a clinical and genetic study.

21 January 2018

1 reference

Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.22156

1 reference

7 November 2017

1 reference